World's Best Scientists 2026 revealed!
Earl D. Silverman

Earl D. Silverman

D-Index & Metrics

Medicine

D-Index
96
Citations
28681
World Ranking
9798
National Ranking
393

Earl D. Silverman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Earl D. Silverman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 387 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Earl D. Silverman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Earl D. Silverman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Earl D. Silverman is affiliated with the University of Toronto in Canada and has made significant contributions to the field of Medicine, particularly focusing on Rheumatology and Immunology.

Their research spans several specialized subfields, including Rheumatology, Immunology, Hematology, Speech and Hearing, and Surgery. The scientist's publication record highlights a concentration on systemic autoimmune and inflammatory disorders, with notable work related to systemic lupus erythematosus and immune cell function.

Main topics of their research include:

  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Adolescent and Pediatric Healthcare
  • Immune Cell Function and Interaction
  • Kawasaki Disease and Coronary Complications
  • Immunodeficiency and Autoimmune Disorders
  • Diabetes and associated disorders

Silverman has published extensively, with a selection of recent papers illustrating the scope of their work:

  • "Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus," 2020, The Journal of Rheumatology
  • "Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial," 2020, Arthritis & Rheumatology
  • "Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis," 2020, The Journal of Rheumatology
  • "Maternal Anti-Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune-Mediated Fetal Heart Disease," 2023, Arthritis & Rheumatology
  • "Effects of Transplacental Dexamethasone Therapy on Fetal Immune-Mediated Complete Heart Block," 2021, Fetal Diagnosis and Therapy

Their research has been featured predominantly in a few key venues:

  • The Journal of Rheumatology (21 publications)
  • Lara D. Veeken (5 publications)
  • Arthritis & Rheumatology (3 publications)
  • Arthritis Care & Research (2 publications)
  • Abstracts (2 publications)

Among Silverman's frequent collaborators are several researchers with whom the scientist has co-authored multiple papers. These include Linda T. Hiraki, Andrea Knight, Deborah M. Levy, Daniela Domínguez, and Lawrence Ng. The breadth of coauthorship indicates active collaboration within their research community.

Best Publications

  • Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Edward H. Giannini;Andreas Reiff;Gail D. Cawkwell

  • Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus

    Hermine I. Brunner;Dafna D. Gladman;Dominique Ibañez;Murray D. Urowitz

  • Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.

    Anath C Lionel;Gregory Costain;Nasim Monfared;Susan Walker

  • A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Nicolino Ruperto;Daniel J. Lovell;Ruben Cuttica;Nick Wilkinson

  • Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.

    Linda T. Hiraki;Susanne M. Benseler;Pascal N. Tyrrell;Diane Hebert

  • Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years

    Edgard Jaeggi;Edgard Jaeggi;Robert M Hamilton;Earl D Silverman;Samuel Antonio Zamora

  • Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Jenny C. Taylor;Jenny C. Taylor;Hilary C. Martin;Stefano Lise;John Broxholme

  • Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease

    Edgar T. Jaeggi;Jean-Claude Fouron;Earl D. Silverman;Greg Ryan

  • Transancestral mapping and genetic load in systemic lupus erythematosus

    Carl D. Langefeld;Hannah C. Ainsworth;Deborah S. Cunninghame Graham;Jennifer A. Kelly

  • Prevalence and burden of pediatric-onset systemic lupus erythematosus.

    Sylvia Kamphuis;Earl D. Silverman

  • Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.

    Hermine I. Brunner;Earl D. Silverman;Theresa To;Claire Bombardier

  • Leflunomide or methotrexate for juvenile rheumatoid arthritis.

    Earl Silverman;Richard Mouy;Lynn Spiegel;Lawrence K. Jung

  • Epidemiology of Juvenile Idiopathic Arthritis in a Multiethnic Cohort Ethnicity as a Risk Factor

    R. K. Saurenmann;J. B. Rose;P. Tyrrell;B. M. Feldman

  • Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study

    R. K. Saurenmann;A. V. Levin;B. M. Feldman;J. B. Rose

  • The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.

    Edgar Jaeggi;Carl Laskin;Robert Hamilton;John Kingdom

  • Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.

    Hermine I. Brunner;Brian M. Feldman;C. Bombardier;Earl D. Silverman

  • Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

    Hermine I Brunner;Nicolino Ruperto;Zbigniew Zuber;Caroline Keane

  • The role of antimalarial agents in the treatment of SLE and lupus nephritis

    Senq J. Lee;Earl Silverman;Joanne M. Bargman

  • Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies.

    Rolando Cimaz;Dawn L. Spence;Lisa Hornberger;Earl D. Silverman

  • Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus

    Chaim O. Jacob;Jiankun Zhu;Don L. Armstrong;Don L. Armstrong;Mei Yan

Frequent Co-Authors

Ronald M. Laxer
Ronald M. Laxer University of Toronto
Brian M. Feldman
Brian M. Feldman University of Toronto
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Janet E. Pope
Janet E. Pope University of Western Ontario
Brian W. McCrindle
Brian W. McCrindle University of Toronto
Paul R. Fortin
Paul R. Fortin Université Laval
Alberto Martini
Alberto Martini University of Genoa
John B. Harley
John B. Harley United States Department of Veterans Affairs
Ann E. Clarke
Ann E. Clarke University of Calgary
Gideon Koren
Gideon Koren Brown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but want to explore alternative or complementary careers, there are several flexible and affordable online degree options in the healthcare field. Many students now pursue healthcare administration, pharmacy, or advanced nursing roles through online programs designed for working professionals.

Those looking to lead in healthcare management may consider enrolling in one of the best online mha programs or search for the cheapest mha programs online healthcare. These degrees can open doors to leadership and executive positions in hospitals, clinics, and other healthcare organizations.

For registered nurses eager to move into advanced practice or leadership, the best online bsn to dnp programs offer a flexible route to a Doctor of Nursing Practice. Pharmacists can also take advantage of distance learning through online pharm d programs to further their education and credentials.

Each path presents unique career opportunities beyond traditional medical school—for those seeking advancement or specialization through online study.

Best Scientists Citing Earl D. Silverman

Trending Scientists

Recently Published Articles